🟢 Pyxis Oncology is trading 6% up today as $50 million financing extends runway

Pyxis Oncology is trading 6% up now at $3.32 as its recent financing-driven rebound continued on August 6, 2026.

• The private placement raised approximately $50 million upfront.
• Warrants could provide another $64 million, extending funding for MICVO clinical development and potentially its cash runway into the second quarter of 2027.
• The financing was explicitly linked to the continuing rally.